THE European Medicines Agency has kicked off a business continuity plan to deal with the "uncertainty and workload implications linked to the UK's withdrawal from the European Union".
Brexit is a key issue for the EMA which is currently based in London and will need to be relocated - along with almost 900 staff.
In its latest update the agency's board confirmed it would select from a list of cities bidding to host the facility at its next meeting in Oct, with European member states keenly vying for the facility.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 17
